Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference39 articles.
1. Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs—results of the British Rheumatoid Outcome Study Group randomised controlled clinical trial;Symmons;Rheumatology,2006
2. Functional disability in rheumatoid arthritis patients compared with a community population in Finland;Sokka;Arthritis Rheum,2003
3. Modified disease activity scores that include twenty-eight-joint counts—development and validation in a prospective longitudinal study of patients with rheumatoid arthritis;Prevoo;Arthritis Rheum,1995
4. Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score;Prevoo;Br J Rheumatol,1996
5. A comparison of validity of single variables and composed indices for measuring disease activity in rheumatoid arthritis;van der Heijde;Ann Rheum Dis,1992
Cited by 680 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE;Rheumatology and Therapy;2024-02-03
2. Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial;Arthritis & Rheumatology;2024-01-18
3. Initial Treatment with Biological Therapy in Rheumatoid Arthritis;Journal of Clinical Medicine;2023-12-21
4. Exploring the role of gut microbiota in advancing personalized medicine;Frontiers in Microbiology;2023-11-30
5. Teplizumab: promises and challenges of a recently approved monoclonal antibody for the prevention of type 1 diabetes or preservation of residual beta cell function;Expert Review of Clinical Immunology;2023-11-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3